$RGEN Income Statement | Understand Stock

$RGEN

$184.69 +$8.89 (5.06%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product Revenue
Royalty and other revenue
Total revenue
Costs and operating expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Change in fair value of contingent consideration
Total costs and operating expenses
Income (loss) from operations
Other income (expense), net:
Investment income
Interest expense
Loss on extinguishment of debt
Amortization of debt issuance costs
Other income (expense), net
Other income, net
Income before income taxes
Income tax provision (benefit)
Net income (loss)
Other comprehensive income (loss):
Unrealized gain on available-for-sale securities, net of tax
Foreign currency translation adjustment
Comprehensive income (loss)
Earnings (loss) per share:
Basic
Diluted
Weighted average common shares outstanding:
Basic
Diluted

Comments